- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04572945
Foot Abnormalities in Diabetic CKD Patients
Foot Abnormalities in Diabetic Patients With and Without Chronic Kidney Disease in Assuit University Hospitals; Case Control Study
- To find the correlation between different stages of CKD and type and severity of foot abnormalities in diabetic patients with CKD.
- To assess factors that may aggravate foot abnormalities in diabetic patients with CKD by measuring serum calcium, phosphorus, parathyroid hormone, albumin, uric acid…etc.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Chronic kidney disease is an important contributor to morbidity and mortality, the global prevalence of CKD was 9.1% (697.5 million cases) in 2017(1). Diabetes is a leading cause of end stage renal disease worldwide. (2) Foot abnormalities and amputation are major health concerns as they diminish health-related quality of life and cause financial burden (3).
KDIGO 2020 defines Chronic Kidney Disease (CKD) as persistently elevated urine albumin excretion (≥30 mg/g [3mg/mmol] creatinine), persistently reduced estimated glomerular filtration rate (eGFR <60 ml/min per 1.73 m2), or both, for greater than 3 months. (4) Diabetic foot is defined as either diabetic peripheral neuropathy, peripheral arterial disease, infection, ulceration, or Charcot osteoarthropathy, or a combination of these abnormalities, in a person diagnosed with diabetes mellitus, according to the guidelines of International Working Group of Diabetic Foot 2020 (IWGDF). (5) There is a much higher incidence of diabetic foot disorder in those with renal disease and outcomes are generally poorer (2) as CKD patients are sharing three main risk factors of foot ulceration and amputation: neuropathy, peripheral arterial disease and increased susceptibility to infection with impaired wound healing. (6)
this research is conducted as little is known about the potential relationship between chronic kidney disease and diabetic foot. This research evaluates the true burden of different diabetic foot lesions in CKD patients, assesses the severity of diabetic foot in different stages of CKD and the factors that may aggravate it in CKD, for future need to modify our clinical policies in management of diabetic foot in CKD patients to provide better prognosis and prevent long term disabilities.
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
The research includes patients recruited from Internal Medicine department Assiut University Hospitals( renal and dialysis unit and diabetes and endocrinal center) , classified into two groups :
- diabetic CKD patient (stage 1- stage 5 non D )
- diabetic CKD patient (stage 5 D)
- written or verbal consent should be taken from those patients that participate in the study.
La description
Inclusion Criteria:
Diabetic CKD patients classified according to estimated GFR into 5 stages according to KIDGO 2012 classification:
Stage 1 CKD: eGFR 90 or Greater Stage 2 CKD: eGFR Between 60 and 89 Stage 3 CKD: eGFR Between 30 and 59 Stage 4 CKD: eGFR Between 15 and 29 Stage 5 CKD: eGFR Less than 15 etheir on dialysis ( satge 5 D) or not (stage 5 non D)
- Age more than ≥18 years
Exclusion Criteria:
- Patients administer drugs causing neuropathy as:amiodarone, chemotherapy, oxazolidinone linezolid, isoniazid, metronidazole, nitrofurantoin ,immunosuppressants, nucleoside reverse transcriptase inhibitors, levodopa and antifungal drugs.
- Patients with other causes of CKD.
- Patients have other causes of PVD.
- Age less than ˂18 years.
- Patients' refusal to participate in the study.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
---|---|
1- Cases: Diabetic patients with CKD.
classified according to estimated GFR into 5 stages according to KIDGO 2012 classification.
|
laboratory and imaging
Autres noms:
|
2- Controls: Diabetic patients without CKD.
defined as patients who have normal kidney function test, normal urine analysis and normal ultrasound findings.
|
laboratory and imaging
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Percentage of foot abnormalities in diabetic CKD patient
Délai: 1 year
|
Percentage of foot abnormalities in diabetic CKD patient in different stages according to KIDGO 2012 classification
|
1 year
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: usra mo farrag, M.B.B.ch, eygpt
Publications et liens utiles
Publications générales
- Carney EF. The impact of chronic kidney disease on global health. Nat Rev Nephrol. 2020 May;16(5):251. doi: 10.1038/s41581-020-0268-7. No abstract available.
- Valabhji J. Foot problems in patients with diabetes and chronic kidney disease. J Ren Care. 2012 Feb;38 Suppl 1:99-108. doi: 10.1111/j.1755-6686.2012.00284.x.
- Ndip A, Lavery LA, Boulton AJ. Diabetic foot disease in people with advanced nephropathy and those on renal dialysis. Curr Diab Rep. 2010 Aug;10(4):283-90. doi: 10.1007/s11892-010-0128-0.
- Hammond N, Wang Y, Dimachkie MM, Barohn RJ. Nutritional neuropathies. Neurol Clin. 2013 May;31(2):477-89. doi: 10.1016/j.ncl.2013.02.002.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Anticipé)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- Diabetic Foot in CKD patients
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur kidney function test
-
Emory UniversityNorthwestern University; Columbia University; Satellite Healthcare; Norman S....ComplétéInsuffisance rénale chronique | Transplantation rénale | Insuffisance rénale en phase terminaleÉtats-Unis
-
Case Comprehensive Cancer CenterMetroHealth Medical Center; Palo Alto UniversityRetiréCancer pédiatrique
-
Cliniques universitaires Saint-Luc- Université...RecrutementBlessure d'ischémie-reperfusion | Greffe du rein; Complications | Fonction de greffe retardée | MitochondrialBelgique
-
CareDxActif, ne recrute pasRejet de greffe de reinÉtats-Unis
-
University Hospital MuensterBioMérieuxRecrutementLésion rénale aiguëEspagne, France, Allemagne, Italie, Pays-Bas, Royaume-Uni, Belgique, Suisse
-
University of Colorado, DenverNational Cancer Institute (NCI)RecrutementCancer pédiatrique | SurvieÉtats-Unis
-
UNC Lineberger Comprehensive Cancer CenterComplétéCancer du sein | MétastaseÉtats-Unis
-
Medical University of ViennaInconnueDysérection | CirrhoseL'Autriche
-
University Hospital, CaenComplétéTroubles neurodéveloppementaux | Comportement de l'enfantFrance
-
Alexandria UniversityComplétéDialyse; ComplicationsEgypte